Rowlings P A, Gale R P, Horowitz M M, Bortin M M
International Bone Marrow Transplant Registry, Milwaukee, WI.
J Hematother. 1994 Fall;3(3):235-8. doi: 10.1089/scd.1.1994.3.235.
Bone marrow transplants are increasingly being used as treatment for leukemia. Several IBMTR studies have identified variables predicting outcome in allogeneic transplants. These studies have also identified factors like GVL that increase our understanding of leukemia treatment. Following the success of HLA-identical sibling transplants, allografts from related and unrelated donors are now performed frequently and achieve long-term LFS. The use of autologous transplants, with and without marrow treatment, is also increasing and continues to be investigated as an alternative therapy for leukemia.
骨髓移植越来越多地被用作白血病的治疗方法。国际骨髓移植登记处(IBMTR)的几项研究已经确定了预测异基因移植结果的变量。这些研究还确定了诸如移植物抗白血病效应(GVL)等因素,加深了我们对白血病治疗的理解。在 HLA 相同的同胞移植取得成功之后,来自相关和无关供体的同种异体移植现在经常进行,并实现了长期无白血病生存(LFS)。自体移植(无论是否进行骨髓处理)的使用也在增加,并且作为白血病的替代疗法仍在继续研究。